5187 |
Developing COVID-19 Vaccines at Pandemic Speed: Potential Vaccine Platform |
Kayvon Modjarrad |
Aug. 06. 20 |
5186 |
Anti-Viral Drugs and Therapies: Hydroxychloroquine, Remdesivir, Plasma, and Others |
Jonathan Grein |
Aug. 06. 20 |
5185 |
Updated Evidence for Left Main PCI vs. CABG: Expert Cardiac Surgeon\'s Perspective |
David Paul Taggart |
Aug. 06. 20 |
5184 |
Long-term(10-Year) Validation of the SYNTAX-II 2020 Score |
Patrick W. Serruys |
Aug. 06. 20 |
5183 |
EXCEL Trial: Extended Long-term and Key Clinical Substudies |
Gregg W. Stone |
Aug. 06. 20 |
5182 |
My Challenging Bifurcation PCI Case of the Year |
Thierry Lefevre |
Aug. 06. 20 |
5181 |
East-Asian Paradox for Antithrombotics: Theory, Evidence and Next Strategy |
Duk-Woo Park |
Aug. 06. 20 |
5180 |
Short DAPT Strategy in the Contemporary PCI Era: Routine or Selective? |
Robert W. Yeh |
Aug. 06. 20 |
5179 |
Escalation and De-Escalation Strategy for DAPT: Rationale and Evidence |
Dominick J. Angiolillo |
Aug. 06. 20 |
5178 |
The DEFINE-FLOW Study: Combined CFR and FFR Lesion Assessment |
Nils Johnson |
Aug. 06. 20 |